Combined use of clinical pre-test probability and D-dimer test in the diagnosis of preoperative deep venous thrombosis in colorectal cancer patients

Summary

The preoperative prevalence of deep venous thrombosis (DVT) in patients with colorectal cancer may be as high as 8%. In order to minimize the risk of pulmonary embolism, it is important to rule out preoperative DVT. A large study has confirmed that a negative D-dimer test in combination with a low clinical pre-test probability (PTP) can be safely used to rule out the tentative diagnosis of DVT in cancer patients. However, the accuracy in colorectal cancer patients is uncertain. This study assessed the diagnostic accuracy of a quantitative D-dimer assay in combination with the PTP score in ruling out preoperative DVT in colorectal cancer patients admitted for surgery. Preoperative D-dimer test and compression ultrasonography for DVT were performed in 193 consecutive patients with newly diagnosed colorectal cancer. Diagnostic accuracy indices of the D-dimer test were assessed according to the PTP score. The negative predictive value, positive predictive value, sensitivity and specificity were 99% (95% confidence interval (CI), 95–100%), 17% (95% CI, 9–26), 93% (95% CI, 68–100%) and 61% (95% CI, 53–68%), respectively. In conclusion, the combined use of pre-test probability and D-dimer test may be useful in ruling out preoperative DVT in colorectal cancer patients admitted for surgery.

Keywords

Colorectal cancer - D-dimer - diagnostic accuracy - preoperative - venous thromboembolism

• References

• 1 Iversen LH, Thorlacius-Ussing O. Relationship of coagulation test abnormalities to tumour burden and postoperative DVT in resected colorectal cancer. Thromb Haemost 2002; 87: 402-408.
• 2 Stender MT, Nielsen TS, Frokjaer JB. et al. High preoperative prevalence of deep venous thrombosis in patients with colorectal cancer. Br J Surg 2007; 94: 1100-1103.
• 3 Ambrus JL, Ambrus CM, Mink IB. et al. Causes of death in cancer patients. J Med 1975; 6: 61-64.
• 4 Donati MB. Cancer and thrombosis. Haemostasis 1994; 24: 128-131.
• 5 Gezelius C, Eriksson A. Neoplastic disease in a medicolegal autopsy material. A retrospective study in northern Sweden. Z Rechtsmed 1988; 101: 115-130.
• 6 Svendsen E, Karwinski B. Prevalence of pulmonary embolism at necropsy in patients with cancer. J Clin Pathol 1989; 42: 805-809.
• 7 Di Nisio M, Rutjes AW, Buller HR. Combined use of clinical pretest probability and D-dimer test in cancer patients with clinically suspected deep venous thrombosis. J Thromb Haemost 2006; 4: 52-57.
• 8 Wells PS, Anderson DR, Rodger M. et al. Evaluation of D-dimer in the diagnosis of suspected deepvein thrombosis. N Engl J Med 2003; 349: 1227-1235.
• 9 Jespersen J, Bertina RM, Haverkate F. Laboratory Techniques in Thrombosis. A Manual. 2nd revised edition of ECAT Assay Procedures.. 1999. Dordrecht/Boston/London: Kluwer Academic Publishers.;
• 10 Larsen TB, Stoffersen E, Christensen CS. et al. Validity of D-dimer tests in the diagnosis of deep vein thrombosis: a prospective comparative study of three quantitative assays. J Intern Med 2002; 252: 36-40.
• 11 Bruns DE, Huth EJ, Magid E. et al. Toward a checklist for reporting of studies of diagnostic accuracy of medical tests. Clin Chem 2000; 46: 893-895.
• 12 Hunt BJ. Plasma D-dimer assays in the diagnosis of venous thromboembolism in cancer patients. J Thromb Haemost 2006; 4: 50-51.
• 13 ten Wolde M, Kraaijenhagen RA, Prins MH. et al. The clinical usefulness of D-dimer testing in cancer patients with suspected deep venous thrombosis. Arch Intern Med 2002; 162: 1880-1884.
• 14 Lee AY, Julian JA, Levine MN. et al. Clinical utility of a rapid whole-blood D-dimer assay in patients with cancer who present with suspected acute deep venous thrombosis. Ann Intern Med 1999; 131: 417-423.
• 15 Leizorovicz A, Cohen AT, Turpie AG. et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004; 110: 874-879.
• 16 Dempfle CE, Zips S, Ergul H. et al. The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT study group. Thromb Haemost 2001; 85: 671-678.
• 17 Sorensen HT, Mellemkjaer L, Olsen JH. et al. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000; 343: 1846-1850.
• 18 Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107: I22-I30.